Humana Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Humana Inc trades at $445 (market cap $46.49B), while Direxion Daily Semiconductor Bull 3X Shares trades at $148.89 (market cap $24.42B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays a 0.91% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| HUM | SOXL | |
|---|---|---|
Market Cap | $46.49B | $24.42B |
Volume | 2,567,704 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.85 | $300.77 |
52-Week Low | $163.67 | $30.81 |
Typical Hold Time | 53 Days | 15 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
SOXL trades at $158.91, down 3.26% over the past 24 hours amid semiconductor sector volatility. Technical indicators show a bullish moving average signal but neutral oscillators, with RSI levels suggesting potential overbought conditions. Recent news highlights mixed sentiment with chip stocks showing strength but leveraged ETF risks remaining prominent. The fund's 3x leverage amplifies both gains and losses in the volatile semiconductor sector.
The outlook for SOXL remains tied to semiconductor sector performance with AI demand providing tailwinds but leverage creating significant risk. Key opportunities include strong GPU demand and semiconductor earnings growth, while risks involve regulatory headwinds, tariff concerns, and the inherent volatility of 3x leveraged ETFs that can magnify losses during market downturns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →